Episode 43 | Dr Margaret Kalmeta, Founder & CTO of BioRegentech

In episode 43, Simon talks to Dr Kalmeta. She presently completed a 25 month international chronic wound project in which her company, BioRegentech, successfully transferred its technology: successfully tested all prototypes of advanced wound medical devices, active substrates, and the associated protocols. This work was a dedication to humanity to prevent one of humanity's greatest suffering, limb amputations. Under Dr. Kalmeta leadership, BioRegentech has grown and currently has 2 divisions: Advanced Wounds and COVID 19.

Every 22 seconds, a leg is amputated and 85% of these amputations are the result of a diabetic foot ulcer. BioRegentech is a new life science company that has developed disruptive technology that can completely heal these open wounds by growing up to four layers of fresh tissue, a completely impossible task for modern medicine. Our mission is to give doctors our advanced tools in order to prevent further amputations, which are especially prevalent in the disproportionately affected populations.